Cargando…

Corrigendum: COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis

Detalles Bibliográficos
Autores principales:	Chu, Zewen, Shi, Xin, Chen, Gaoyang, He, Xuejun, Qian, Yayun, Wang, Haibo, Tao, Li, Liu, Yanqing, Jiang, Wei, Chen, Jue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766711/ https://www.ncbi.nlm.nih.gov/pubmed/35069227 http://dx.doi.org/10.3389/fphar.2021.831941

Ejemplares similares

COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis
por: Chu, Zewen, et al.
Publicado: (2021)

Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K
por: Wang, Hua, et al.
Publicado: (2016)

miR-141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression
por: Li, Guoxiong, et al.
Publicado: (2018)

Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma
por: Kim, Hee Sung, et al.
Publicado: (2019)

Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion
por: Jue, Chen, et al.
Publicado: (2016)

Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling
por: Jue, Chen, et al.
Publicado: (2016)

Epithelial-Mesenchymal Transition Regulated by EphA2 Contributes to Vasculogenic Mimicry Formation of Head and Neck Squamous Cell Carcinoma
por: Wang, Wei, et al.
Publicado: (2014)

Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells
por: Kim, Hee Sung, et al.
Publicado: (2019)

Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023)

Slug promoted vasculogenic mimicry in hepatocellular carcinoma
por: Sun, Dan, et al.
Publicado: (2013)

Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells
por: Han, Deok-Soo, et al.
Publicado: (2022)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma
por: Xie, Jing, et al.
Publicado: (2021)

Function of BMP4 in the Formation of Vasculogenic Mimicry in Hepatocellular Carcinoma
por: Li, Xiao, et al.
Publicado: (2020)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Homocysteine Impairs Endothelial Cell Barrier Function and Angiogenic Potential via the Progranulin/EphA2 Pathway
por: Tian, Dan, et al.
Publicado: (2021)

ROCK Is Involved in Vasculogenic Mimicry Formation in Hepatocellular Carcinoma Cell Line
por: Zhang, Ji-Gang, et al.
Publicado: (2014)

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

Advanced research on vasculogenic mimicry in cancer
por: Qiao, Lili, et al.
Publicado: (2015)

Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
por: Ayala-Domínguez, Lízbeth, et al.
Publicado: (2019)

An Overview of Vasculogenic Mimicry in Breast Cancer
por: Andonegui-Elguera, Marco A., et al.
Publicado: (2020)

Vasculogenic mimicry in carcinogenesis and clinical applications
por: Luo, Qingxi, et al.
Publicado: (2020)

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts
por: Zhang, Chunyu, et al.
Publicado: (2023)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011)

Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status
por: He, Xuejun, et al.
Publicado: (2021)

Human herpesvirus 8 molecular mimicry of ephrin ligands facilitates cell entry and triggers EphA2 signaling
por: Light, Taylor P., et al.
Publicado: (2021)

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
por: Wei, Xiaoxu, et al.
Publicado: (2021)

Vasculogenic mimicry: a novel target for glioma therapy
por: Chen, Yin-Sheng, et al.
Publicado: (2014)

Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway
por: Zhu, Yingjun, et al.
Publicado: (2020)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Xiang, Tong, et al.
Publicado: (2018)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

Vasculogenic mimicry in small cell lung cancer
por: Williamson, Stuart C., et al.
Publicado: (2016)

Structural and functional identification of vasculogenic mimicry in vitro
por: Racordon, Dusan, et al.
Publicado: (2017)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
por: López-Camarillo, César, et al.
Publicado: (2020)

Platelets disrupt vasculogenic mimicry by cancer cells
por: Martini, Carmela, et al.
Publicado: (2020)

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9phhhbaao5s04g0v12bgmsm13q